Navigation Links
Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
Date:8/14/2009

e we will have consistent growth for the rest of the year mainly because the majority of drugs we sell to our national network are covered under the National Health Insurance Policy, and our continuous efforts to improve operational efficiency," said Mr. Liu. "While we are making progress in expanding our production capacity in Inner Mongolia, we believe we are on track to achieve the earnings guidance we provided previously."

    (1) The 2008 net revenues referenced above have been adjusted for
        correction. While the total net revenues remain unchanged in
        comparison with the previously reported numbers, the allocation of
        three revenue segments is revised as follows:

                  For the Three Months Ended    For the Six Months Ended
                            June 30,                  June 30,
                              2008                      2008
    NET REVENUES:
       Wholesale           $14,235,345                $22,672,643
       Retail                3,644,530                  5,661,077
       Other revenues        1,505,737                 2,761,069

    Total Net Revenues     $19,385,612                $31,094,789

About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )

Lotus Pharmaceuticals, Inc. is a growing developer and producer of prescription drugs and a licensed national seller of pharmaceutical items in the People's Republic of China. Lotus operates Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus's current drug development pipeline is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. More than 8,000 products are sold by Liang Fang directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces.

Safe Harbor Statement

<
'/>"/>
SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
2. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
3. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
4. NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
5. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
6. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
7. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
8. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
10. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 This market report summarizes ... profiling carried out in May 2013. The full ... of the responses for each question, its segmentation ... also highlights some interesting differences, particularly between Pharma, ... models were developed to estimate the in house ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Quincy ... discovery and development of calcium-binding proteins to support ... safety assessment study of apoaequorin in ... journal published for the British Industrial Biological Research ... was to investigate potential adverse effects, if any, ...
(Date:5/23/2013)... -- BioScrip, Inc. (NASDAQ: BIOS ) today announced ... Global Healthcare Conference to be held June 3-6, 2013 ... Richard Smith , President and Chief Executive ... Financial Officer, will present on Monday, June 3, 2013 ... About BioScrip BioScrip, Inc. provides comprehensive infusion and ...
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
Breaking Biology Technology:Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
... , SUNNYVALE, Calif., Sept. 3 Pharmacyclics, ... on developing and commercializing innovative small molecule drugs for the ... Dr. Glenn Rice, President and COO, will provide a business ... -- Thomas Weisel Partners 2009 Healthcare Conference at the Four ...
... , NEW YORK, Sept. 3 Reportlinker.com announces ... , , Smart Glass: Technologies and ... , , This report: , ... overview of smart glass technology , Describes ...
... , , TONBRIDGE, ... are trapped in a postcode lottery after Department of Health (DH) ... over who is eligible for the jab. , , ... Health Authority (SHA) has advised all Primary Care Trusts (PCTs) in ...
Cached Biology Technology:Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences 2Reportlinker Adds Smart Glass: Technologies and Global Markets Report 2Reportlinker Adds Smart Glass: Technologies and Global Markets Report 3Health Workers Face Postcode Lottery for Swine Flu Vaccine, Chemist+Druggist Reveals 2
(Date:5/24/2013)... search for medication against Alzheimer,s disease, scientists have focused ... Amyloid beta (A-beta). After all, it is the accumulation of ... Alzheimer,s patients. Starting point for the formation of A-beta is ... first to unravel the function of APPL the fruit-fly ... flies. , Alessia Soldano (VIB/KU Leuven): "We have discovered ...
(Date:5/23/2013)... be the world,s most popular fruit, can be made ... purple GM varieties. , "Working with GM tomatoes ... addition of a specific compound, allows us to pinpoint ... Cathie Martin from the John Innes Centre. , The ... flavour, health and shelf life characteristics because even higher ...
(Date:5/23/2013)... at Rollins School of Public Health at Emory ... of Technology, have received a $4 million grant ... at Emory University (Health and Exposome Research Center: ... exposome-based center grant awarded in the United States. ... the National Institute of Environmental Health Sciences (NIEHS) ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2The world's favorite fruit only better-tasting and longer-lasting 2Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
... one in every 500 to 650 baby boys is born ... code that until a few years ago was thought to ... longer the case. A recent conference hosted by NewYork-Presbyterian Hospital/Weill ... awareness of the condition and the recent availability of treatments ...
... of the most widely used undergraduate textbook in molecular ... just been released. It incorporates the latest in ... of earlier editions that have made this a superior ... authors with outstanding teaching and research credentials, the book ...
... say ,I won,t kiss you, I,ve got a cold,. But a ... risk of passing on an infection by shaking someone,s hand than ... the United States and the UK have published the first detailed ... in hospital and healthcare settings. Their findings are published in the ...
Cached Biology News:Physician-scientists seek solutions to reproductive problems related to chromosomal variations 2Physician-scientists seek solutions to reproductive problems related to chromosomal variations 3New edition of a classic molecular biology textbook from CSHL Press and Benjamin Cummings 2If you don't want to fall ill this Christmas, then share a festive kiss but don't shake hands 2If you don't want to fall ill this Christmas, then share a festive kiss but don't shake hands 3
... EPICENTREs patented MasterAmp™ 10X PCR Enhancer ... and allows improved sensitivity and specificity ... Using MasterAmp PCR Enhancer in PCR ... DNA melting, increases enzyme?s thermal stability, ...
... Polystyrene covers can be ... Ridged covers for stacking ... Non-ridged covers for use with ... covers, ridged and non-ridged, are ...
Designed for use with all 96-well SPRI reagent kits. Used with round bottom 96-well microplates, and 96-well thermal cycling plates....
... Streptavidin-HRP Systems provide rapid, precise localization ... in frozen or paraffin-embedded tissue, cytospins ... also facilitate double or triple labeleing ... simultaneously with primary antibodies of different ...
Biology Products: